
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.62 | 0.62 | 0.00 |
Shares | 98.36 | 98.36 | 0.00 |
Convertible | 0.04 | 0.04 | 0.00 |
Preferred | 0.45 | 0.45 | 0.00 |
Other | 0.53 | 0.53 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.94 | 18.98 |
Price to Book | 4.14 | 4.34 |
Price to Sales | 1.60 | 2.38 |
Price to Cash Flow | 13.84 | 15.52 |
Dividend Yield | 1.34 | 1.18 |
5 Years Earnings Growth | 8.55 | 10.53 |
Number of long holdings: 106
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.87 | 732.58 | +0.08% | |
UnitedHealth | US91324P1021 | 4.52 | 309.80 | +2.48% | |
AstraZeneca | GB0009895292 | 4.15 | 11,790.0 | -0.17% | |
Boston Scientific | US1011371077 | 3.45 | 105.55 | -0.19% | |
Abbott Labs | US0028241000 | 3.42 | 132.66 | +0.98% | |
J&J | US4781601046 | 3.15 | 177.14 | +0.96% | |
Sanofi | FR0000120578 | 2.90 | 84.49 | -1.02% | |
Novartis ADR | US66987V1098 | 2.65 | 126.55 | +0.06% | |
Amgen | US0311621009 | 2.55 | 287.71 | +0.74% | |
AbbVie | US00287Y1091 | 2.52 | 210.40 | +1.19% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Research D | 19.45B | 13.21 | 25.25 | 15.00 | ||
Janus Balanced I | 12.41B | 9.22 | 11.33 | 9.44 | ||
Janus Enterprise I | 9.92B | 4.65 | 11.07 | 12.02 | ||
Janus Henderson Balanced Portfolio | 8.85B | 9.16 | 11.13 | 9.17 | ||
Janus Enterprise N | 6.8B | 4.71 | 11.18 | 12.13 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review